Based on recent data, Estrella Immunopharma, Inc. (ESLA) shows an Average True Range (ATR) of 0.16 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 178.59K, indicating liquidity. These fundamental metrics provide insight into ESLA's underlying financial health and market activity.
| ATR | 0.16 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 178.59K |
| Avg Vol (10 Days) | 86.77K |
Estrella Immunopharma, Inc. (ESLA) technical indicators as of March 26, 2026: the SMA 20 is -2.36%, SMA 50 at -5.78%, and SMA 200 at -7.86%. The RSI 14 value is 47.55, suggesting its current momentum. These technical analysis signals help assess ESLA's price trends and potential future movements.
| SMA 20 | -2.36% |
| SMA 50 | -5.78% |
| SMA 200 | -7.86% |
| RSI 14 | 47.55 |
Estrella Immunopharma, Inc. (ESLA) stock performance overview as of March 26, 2026: The 52-week high is $3.15 (currently -61.9% below), and the 52-week low is $0.73 (currently 64.36% above). Over the past year, ESLA's performance is -22.27%, compared to the S&P 500's 14.34% change.
| 52-Week High | 3.15 |
| 52-Week High Chg | -61.90% |
| 52-Week Low | 0.7301 |
| 52-Week Low Chg | +64.36% |
| S&P 500 52-Week Chg | 14.34% |
According to market data, Estrella Immunopharma, Inc. (ESLA) stock's recent performance metrics show that over the last month, ESLA is -41.6%, with a Year-to-Date (YTD) performance of -41.6%. Over the past year, the stock has seen a -22.27% change. These figures summarize ESLA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.18 | 1.37 | 1.8 | 3.15 | 3.15 | 1.54 |
| Low | 0.97 | 0.97 | 0.9002 | 0.9002 | 0.7301 | 0.9002 |
| Performance | -14.06% | -41.60% | -47.94% | +8.45% | -22.27% | -41.60% |
According to current financial data, ESLA stock's P/E (TTM) ratio is -3.02, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ESLA, including P/S (N/A), P/B (-3.81), and P/FCF (-24.85), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ESLA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.02 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | -3.81 | 8.25 | 4.77 | 4.62 |
| P/FCF (TTM) | -24.85 | 72.79 | -221.03 | 32.15 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep